Browsing by Author "Barbara Dapas"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication An Overview of siRNA Delivery Strategies for Urological Cancers(MDPI, 2022) ;Nadia Halib ;Nicola Pavan ;Carlo Trombetta ;Barbara Dapas ;Rossella Farra ;Bruna Scaggiante ;Mario GrassiGabriele GrassiThe treatment of urological cancers has been significantly improved in recent years. However, for the advanced stages of these cancers and/or for those developing resistance, novel therapeutic options need to be developed. Among the innovative strategies, the use of small interfering RNA (siRNA) seems to be of great therapeutic interest. siRNAs are double-stranded RNA molecules which can specifically target virtually any mRNA of pathological genes. For this reason, siRNAs have a great therapeutic potential for human diseases including urological cancers. However, the fragile nature of siRNAs in the biological environment imposes the development of appropriate delivery systems to protect them. Thus, ensuring siRNA reaches its deep tissue target while maintaining structural and functional integrity represents one of the major challenges. To reach this goal, siRNA-based therapies require the development of fine, tailor-made delivery systems. Polymeric nanoparticles, lipid nanoparticles, nanobubbles and magnetic nanoparticles are among nano-delivery systems studied recently to meet this demand. In this review, after an introduction about the main features of urological tumors, we describe siRNA characteristics together with representative delivery systems developed for urology applications; the examples reported are subdivided on the basis of the different delivery materials and on the different urological cancers. - Some of the metrics are blocked by yourconsent settings
Publication Potential applications of nanocellulose-containing materials in the biomedical field(MDPI AG, 2017) ;Nadia Halib ;Francesca Perrone ;Maja Cemazar ;Barbara Dapas ;Rossella Farra ;Michela Abrami ;Gianluca Chiarappa ;Giancarlo Forte ;Fabrizio Zanconati ;Gabriele Pozzato ;Luigi Murena ;Nicola Fiotti ;Romano Lapasin ;Laura Cansolino ;Gabriele Grassi ;Mario Grassi ;Faculty of Dentistry ;Universiti Sains Islam Malaysia (USIM) ;Trieste University ;Institute of Oncology Ljubljana ;University of Trieste ;St. Anne's University HospitaUniversity of Pavia and IRCCS SBecause of its high biocompatibility, bio-degradability, low-cost and easy availability, cellulose finds application in disparate areas of research. Here we focus our attention on the most recent and attractive potential applications of cellulose in the biomedical field. We first describe the chemical/structural composition of cellulose fibers, the cellulose sources/features and cellulose chemical modifications employed to improve its properties. We then move to the description of cellulose potential applications in biomedicine. In this field, cellulose is most considered in recent research in the form of nano-sized particle, i.e., nanofiber cellulose (NFC) or cellulose nanocrystal (CNC). NFC is obtained from cellulose via chemical and mechanical methods. CNC can be obtained from macroscopic or microscopic forms of cellulose following strong acid hydrolysis. NFC and CNC are used for several reasons including the mechanical properties, the extended surface area and the low toxicity. Here we present some potential applications of nano-sized cellulose in the fields of wound healing, bone-cartilage regeneration, dental application and different human diseases including cancer. To witness the close proximity of nano-sized cellulose to the practical biomedical use, examples of recent clinical trials are also reported. Altogether, the described examples strongly support the enormous application potential of nano-sized cellulose in the biomedical field. � 2017 by the authors.